Crescent Grove Advisors’s Daxor DXR Stock Holding History

Crescent Grove Advisors’s Portfolio DXR Stock Details DXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$140K	Hold	12,423	–	–	0.01%	319
2026 Q2	$128K	Buy	12,423 +1,700	+16%	+$17.2K	0.01%	296
2026 Q1	$104K	Buy	+10,723	New	+$131K	0.01%	300

Other funds holding DXR

Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

BPI

BFC Planning, Inc. Cedar Rapids, Iowa $2.55B AUM 30.11% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $140M AUM 44.76% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Crescent Grove Advisors's DXR Position: Q3 2026 in Review

Crescent Grove Advisors held its Daxor (DXR) position steady in Q3 2026 at 12,423 shares worth $140K. The position accounts for 0.01% of the portfolio, ranked #319.

Crescent Grove Advisors first reported a position in DXR in Q1 2026 and has held it in 3 quarters since. 15 funds tracked by Wall St. Rank hold DXR as of Q3 2026.

Crescent Grove Advisors held 12,423 shares of Daxor worth $140K as of Q3 2026.
Crescent Grove Advisors left its Daxor share count unchanged in Q3 2026.
Daxor made up 0.01% of Crescent Grove Advisors's portfolio in Q3 2026, its #319 holding.
Crescent Grove Advisors first reported a position in Daxor in Q1 2026 and has held it in 3 quarters since.
15 funds tracked by Wall St. Rank held Daxor as of Q3 2026.

Based on Crescent Grove Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.